Matches in SemOpenAlex for { <https://semopenalex.org/work/W3095051727> ?p ?o ?g. }
- W3095051727 endingPage "1147" @default.
- W3095051727 startingPage "1129" @default.
- W3095051727 abstract "New approaches to cancer immunotherapy have been developed, showing the ability to harness the immune system to treat and eliminate cancer. For many solid tumors, therapy with checkpoint inhibitors has shown promise. For hematologic malignancies, adoptive and engineered cell therapies are being widely developed, using cells such as T lymphocytes, as well as natural killer (NK) cells, dendritic cells, and potentially others. Among these adoptive cell therapies, the most active and advanced therapy involves chimeric antigen receptor (CAR)-T cells, which are T cells in which a chimeric antigen receptor is used to redirect specificity and allow T cell recognition, activation and killing of cancers, such as leukemia and lymphoma. Two autologous CAR-T products have been approved by several health authorities, starting with the U.S. Food and Drug Administration (FDA) in 2017. These products have shown powerful, inducing, long-lasting effects against B cell cancers in many cases. In distinction to the results seen in hematologic malignancies, the field of using CAR-T products against solid tumors is in its infancy. Targeting solid tumors and trafficking CAR-T cells into an immunosuppressive microenvironment are both significant challenges. The goal of this review is to summarize some of the most recent aspects of CAR-T cell design and manufacturing that have led to successes in hematological malignancies, allowing the reader to appreciate the barriers that must be overcome to extend CAR-T therapies to solid tumors successfully." @default.
- W3095051727 created "2020-11-09" @default.
- W3095051727 creator A5024571521 @default.
- W3095051727 creator A5051135510 @default.
- W3095051727 creator A5059447343 @default.
- W3095051727 creator A5076201188 @default.
- W3095051727 creator A5077440294 @default.
- W3095051727 creator A5081219684 @default.
- W3095051727 creator A5082066396 @default.
- W3095051727 creator A5090412384 @default.
- W3095051727 date "2021-05-01" @default.
- W3095051727 modified "2023-10-14" @default.
- W3095051727 title "CAR-T cells: Early successes in blood cancer and challenges in solid tumors" @default.
- W3095051727 cites W127707871 @default.
- W3095051727 cites W1556687169 @default.
- W3095051727 cites W1623064933 @default.
- W3095051727 cites W1817778246 @default.
- W3095051727 cites W1884460322 @default.
- W3095051727 cites W1932328926 @default.
- W3095051727 cites W1963522404 @default.
- W3095051727 cites W1964514079 @default.
- W3095051727 cites W1964809183 @default.
- W3095051727 cites W1975653912 @default.
- W3095051727 cites W1984287161 @default.
- W3095051727 cites W1984832220 @default.
- W3095051727 cites W1987504267 @default.
- W3095051727 cites W1987849309 @default.
- W3095051727 cites W1991985021 @default.
- W3095051727 cites W1993778590 @default.
- W3095051727 cites W2003080345 @default.
- W3095051727 cites W2005263482 @default.
- W3095051727 cites W2007753570 @default.
- W3095051727 cites W2009914447 @default.
- W3095051727 cites W2012108097 @default.
- W3095051727 cites W2015415347 @default.
- W3095051727 cites W2017277108 @default.
- W3095051727 cites W2023382813 @default.
- W3095051727 cites W2025068963 @default.
- W3095051727 cites W2030612376 @default.
- W3095051727 cites W2032199025 @default.
- W3095051727 cites W2035838265 @default.
- W3095051727 cites W2036144830 @default.
- W3095051727 cites W2036970197 @default.
- W3095051727 cites W2039638023 @default.
- W3095051727 cites W2039766705 @default.
- W3095051727 cites W2045475405 @default.
- W3095051727 cites W2047192675 @default.
- W3095051727 cites W2050795855 @default.
- W3095051727 cites W2051549641 @default.
- W3095051727 cites W2052279202 @default.
- W3095051727 cites W2060813234 @default.
- W3095051727 cites W2064283997 @default.
- W3095051727 cites W2064341586 @default.
- W3095051727 cites W2067319054 @default.
- W3095051727 cites W2068302119 @default.
- W3095051727 cites W2071966111 @default.
- W3095051727 cites W2073310925 @default.
- W3095051727 cites W2077171467 @default.
- W3095051727 cites W2083172345 @default.
- W3095051727 cites W2085060041 @default.
- W3095051727 cites W2087055812 @default.
- W3095051727 cites W2087134443 @default.
- W3095051727 cites W2087857484 @default.
- W3095051727 cites W2093112418 @default.
- W3095051727 cites W2094945699 @default.
- W3095051727 cites W2099570622 @default.
- W3095051727 cites W2105400883 @default.
- W3095051727 cites W2110641339 @default.
- W3095051727 cites W2111740872 @default.
- W3095051727 cites W2114147900 @default.
- W3095051727 cites W2118756622 @default.
- W3095051727 cites W2118796952 @default.
- W3095051727 cites W2120259831 @default.
- W3095051727 cites W2122459559 @default.
- W3095051727 cites W2128895268 @default.
- W3095051727 cites W2129702476 @default.
- W3095051727 cites W2130011407 @default.
- W3095051727 cites W2130338247 @default.
- W3095051727 cites W2131493981 @default.
- W3095051727 cites W2132042881 @default.
- W3095051727 cites W2133215361 @default.
- W3095051727 cites W2133298966 @default.
- W3095051727 cites W2133484118 @default.
- W3095051727 cites W2134012905 @default.
- W3095051727 cites W2136280424 @default.
- W3095051727 cites W2136371915 @default.
- W3095051727 cites W2145985838 @default.
- W3095051727 cites W2148226248 @default.
- W3095051727 cites W2156106286 @default.
- W3095051727 cites W2157307300 @default.
- W3095051727 cites W2163252214 @default.
- W3095051727 cites W2163695893 @default.
- W3095051727 cites W2164414797 @default.
- W3095051727 cites W2165836181 @default.
- W3095051727 cites W2166729052 @default.
- W3095051727 cites W2169579205 @default.
- W3095051727 cites W2169876627 @default.
- W3095051727 cites W2171082742 @default.